David Cory Net Worth & Insider Trades

David Cory - President and CEO, Eiger Biopharmaceuticals, Inc

As of March 11, 2022

What is David Cory's Net Worth?

The current estimated net worth of Eiger Biopharmaceuticals, Inc's President and CEO, David Cory, is estimated to be about $429.25K . David Cory owns about 96,126 units of Eiger Biopharmaceuticals, Inc common stock. In the last 6 years at Eiger Biopharmaceuticals, Inc, David Cory has sold an estimated value of $0 worth.

What is David Cory's Past Insider Trading?

David Cory's largest purchase order was 1,562 units , worth over $24.52K on August 19, 2016. In total, David Cory has made about 11 transactions over 6 years of their time at Eiger Biopharmaceuticals, Inc. David Cory usually trades in March, with the busiest year in 2019. The most recent transaction was a purchase order of 343 units , worth over $3.86K on April 26, 2019.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was David Cory's Salary in 2020?

As President and CEO of Eiger Biopharmaceuticals, Inc, David Cory has a total base salary of $590,584 . David Cory received compensation valued at about $1,830,179 in 2020 after becoming President and CEO. The vast majority of their compensation came in the form of option awards of $829,564 , other earnings, plans or compensations of $393,360 , and other compensation of $16,671 .

What is David Cory's' Mailing Address?

  • Mailing address is 350 Cambridge Avenue, Suite 350 Palo Alto CA 94306 CA

Eiger Biopharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
David A. Cory 2020 $590,584 - - $829,564 $393,360 $16,671 $1,830,179
David A. Cory 2019 $565,833 - - $2,009,820 $285,000 $11,200 $2,871,853
Sriram Ryali 2020 $381,550 - - $234,442 $173,272 $12,296 $801,559
Sriram Ryali 2019 $335,000 - - $662,211 $117,250 $9,732 $1,124,193
Eldon Mayer 2020 $385,569 $100,000 $92,700 $1,199,520 $169,256 $2,328 $1,949,373
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1305253/000119312521137193/d146195ddef14a.htm

What are Eiger Biopharmaceuticals, Inc's Past Insider Trades?

Eiger Biopharmaceuticals, Inc's most recent insider trade came on August 18, 2022 by David Apelian who sold 5,000 units worth $49.03K . In the last 6 years, insiders at Eiger Biopharmaceuticals, Inc have sold an estimated value of $3.02M and bought an estimated value of $4.61M worth of shares. Insider trading is most common in March, with the busiest year in 2019. The most active traders at the company are John Thomas Dietz,  Eldon Mayer III, Ex VP & Chief Commerc. Officer,  and David Cory, President and CEO .

Eiger BioPharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1